Back to VRCA
UBS Group AG VRCA Position History
Verrica Pharmaceuticals Inc. • Healthcare
Quarters held
9
Latest value
$7K
Q3 2026
Peak value
$179K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $112 |
| Q3 2025 | $179K |
| Q4 2025 | $199 |
| Q1 2026 | $116 |
| Q1 2026 | $22K |
| Q2 2026 | $135 |
| Q2 2026 | $37K |
| Q3 2026 | $105 |
| Q3 2026 | $7K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $7K | 1.4K | — | — |
| Q3 2026 | $105 | 22 | — | — |
| Q2 2026 | $37K | 6.0K | — | — |
| Q2 2026 | $135 | 22 | — | — |
| Q1 2026 | $22K | 4.2K | — | — |
| Q1 2026 | $116 | 22 | — | — |
| Q4 2025 | $199 | 24 | — | — |
| Q3 2025 | $179K | 41.6K | — | — |
| Q3 2025 | $112 | 26 | — | — |
Other funds holding VRCA
$11M
$8.9M
$8.8M
$8.1M
$7.7M
$6.7M